N-(4-bromophenyl)-2-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)hydrazinecarbothioamide

ID: ALA4279660

Chembl Id: CHEMBL4279660

PubChem CID: 145979415

Max Phase: Preclinical

Molecular Formula: C23H20BrN5O2S

Molecular Weight: 510.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(-n2c(NNC(=S)Nc3ccc(Br)cc3)nc3ccccc3c2=O)cc1

Standard InChI:  InChI=1S/C23H20BrN5O2S/c1-2-31-18-13-11-17(12-14-18)29-21(30)19-5-3-4-6-20(19)26-22(29)27-28-23(32)25-16-9-7-15(24)8-10-16/h3-14H,2H2,1H3,(H,26,27)(H2,25,28,32)

Standard InChI Key:  VQKIIGRHDRSPCE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4279660

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.42Molecular Weight (Monoisotopic): 509.0521AlogP: 4.86#Rotatable Bonds: 6
Polar Surface Area: 80.21Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.07CX Basic pKa: 2.67CX LogP: 5.62CX LogD: 5.62
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.25Np Likeness Score: -1.74

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source